Biolife Solutions (BLFS) Gross Margin (2010 - 2026)
Biolife Solutions (BLFS) reported Gross Margin of 63.62% for Q1 2026, down 349.0% year-over-year from 25.55% in Q1 2025, and up 260.33% quarter-over-quarter from 39.68% in Q4 2025.
Biolife Solutions (BLFS) Gross Margin (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has 17 years of Gross Margin data on file, last reported at 63.62% in Q1 2026.
- Gross Margin for Q1 2026 came in at 63.62%, down 349.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 58.4% (down 400.0% YoY), and the FY2025 annual result was 64.56%, down 255.0% from the prior year.
- Gross Margin improved to 63.62% in Q1 2026 per BLFS's latest filing, from 39.68% in the prior quarter.
- Over five years, Gross Margin peaked at 199.94% in Q4 2023 and troughed at 39.68% in Q4 2025.
- A 5-year average of 77.65% and a median of 86.9% in 2023 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2023 and 2024: Gross Margin jumped 10946 bps in 2023, then slumped 21368 bps in 2024.
- A 5-year view of Gross Margin shows it stood at 90.48% in 2022, then soared by 121 bps to 199.94% in 2023, then tumbled by 107 bps to 13.75% in 2024, then plunged by 189 bps to 39.68% in 2025, then jumped by 260 bps to 63.62% in 2026.
- Business Quant data shows BLFS's Gross Margin at 63.62% in Q1 2026, 39.68% in Q4 2025, and 90.99% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 66.06% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 45.69% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 25.04% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 62.25% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 35.08% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 54.66% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 68.00% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 70.82% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 32.99% |
| 10 | Biolife Solutions | 1.27 Bn | 1.19 Bn | 17.50 Mn | 63.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.62% |
| Dec 31, 2025 | -39.68% |
| Sep 30, 2025 | 90.99% |
| Jun 30, 2025 | 89.25% |
| Mar 31, 2025 | 67.11% |
| Dec 31, 2024 | -13.75% |
| Sep 30, 2024 | 88.28% |
| Jun 30, 2024 | 87.41% |
| Mar 31, 2024 | 87.11% |
| Dec 31, 2023 | 199.94% |
| Sep 30, 2023 | 79.32% |
| Jun 30, 2023 | 86.90% |
| Mar 31, 2023 | 82.84% |
| Dec 31, 2022 | 90.48% |
| Sep 30, 2022 | 87.05% |
| Jun 30, 2022 | 86.64% |
| Mar 31, 2022 | 86.50% |
| Dec 31, 2021 | 87.19% |
| Sep 30, 2021 | 87.97% |
| Jun 30, 2021 | 89.93% |